TNFSF10 and ameloblastoma: A study on tumour necrosis factor–related apoptosis-inducing ligand (TRAIL) reported that ameloblastoma has an anti-apoptotic proliferation site in the periphery and a pro-apoptotic differentiation site in the centre of the parenchyma tumour8.